GO:0003674 | molecular_function | 64.75% (79/122) | 0.87 | 0.0 | 0.0 |
GO:0005488 | binding | 50.0% (61/122) | 1.15 | 0.0 | 0.0 |
GO:0005575 | cellular_component | 40.98% (50/122) | 1.04 | 0.0 | 2.1e-05 |
GO:0097159 | organic cyclic compound binding | 31.97% (39/122) | 1.15 | 1e-06 | 0.000106 |
GO:0009987 | cellular process | 36.89% (45/122) | 1.0 | 1e-06 | 0.000161 |
GO:0008150 | biological_process | 46.72% (57/122) | 0.75 | 7e-06 | 0.000559 |
GO:0004157 | dihydropyrimidinase activity | 1.64% (2/122) | 9.1 | 6e-06 | 0.000588 |
GO:0008152 | metabolic process | 31.97% (39/122) | 0.99 | 1e-05 | 0.000604 |
GO:0006807 | nitrogen compound metabolic process | 27.05% (33/122) | 1.16 | 6e-06 | 0.000615 |
GO:0003743 | translation initiation factor activity | 3.28% (4/122) | 5.01 | 9e-06 | 0.000623 |
GO:1901575 | organic substance catabolic process | 9.02% (11/122) | 2.39 | 1e-05 | 0.000639 |
GO:0110165 | cellular anatomical entity | 33.61% (41/122) | 0.93 | 1.7e-05 | 0.000799 |
GO:0009056 | catabolic process | 9.02% (11/122) | 2.31 | 1.5e-05 | 0.000843 |
GO:0006139 | nucleobase-containing compound metabolic process | 14.75% (18/122) | 1.65 | 1.7e-05 | 0.00086 |
GO:0071704 | organic substance metabolic process | 30.33% (37/122) | 0.99 | 2.1e-05 | 0.000917 |
GO:0035639 | purine ribonucleoside triphosphate binding | 15.57% (19/122) | 1.56 | 2.4e-05 | 0.000969 |
GO:0032991 | protein-containing complex | 13.93% (17/122) | 1.59 | 5e-05 | 0.001277 |
GO:0008135 | translation factor activity, RNA binding | 3.28% (4/122) | 4.35 | 5e-05 | 0.001321 |
GO:0090079 | translation regulator activity, nucleic acid binding | 3.28% (4/122) | 4.35 | 5e-05 | 0.001321 |
GO:0044238 | primary metabolic process | 28.69% (35/122) | 1.0 | 3.4e-05 | 0.001337 |
GO:0006208 | pyrimidine nucleobase catabolic process | 1.64% (2/122) | 7.84 | 3.7e-05 | 0.001344 |
GO:0044237 | cellular metabolic process | 24.59% (30/122) | 1.07 | 6e-05 | 0.001361 |
GO:0006725 | cellular aromatic compound metabolic process | 14.75% (18/122) | 1.52 | 5.6e-05 | 0.001369 |
GO:0046483 | heterocycle metabolic process | 14.75% (18/122) | 1.55 | 4.2e-05 | 0.001376 |
GO:0003676 | nucleic acid binding | 17.21% (21/122) | 1.39 | 4.6e-05 | 0.001391 |
GO:1901564 | organonitrogen compound metabolic process | 19.67% (24/122) | 1.25 | 6e-05 | 0.001404 |
GO:0044248 | cellular catabolic process | 6.56% (8/122) | 2.68 | 4.1e-05 | 0.001406 |
GO:0072529 | pyrimidine-containing compound catabolic process | 1.64% (2/122) | 7.62 | 5e-05 | 0.001426 |
GO:0016070 | RNA metabolic process | 9.84% (12/122) | 2.02 | 4.6e-05 | 0.001432 |
GO:1901360 | organic cyclic compound metabolic process | 14.75% (18/122) | 1.48 | 8.1e-05 | 0.001721 |
GO:0046113 | nucleobase catabolic process | 1.64% (2/122) | 7.24 | 8.4e-05 | 0.001736 |
GO:0034641 | cellular nitrogen compound metabolic process | 14.75% (18/122) | 1.46 | 9e-05 | 0.001737 |
GO:0003723 | RNA binding | 9.02% (11/122) | 2.03 | 8.8e-05 | 0.001758 |
GO:0045182 | translation regulator activity | 3.28% (4/122) | 4.17 | 8.1e-05 | 0.001777 |
GO:0046033 | AMP metabolic process | 1.64% (2/122) | 7.1 | 0.000104 | 0.001844 |
GO:0005515 | protein binding | 18.03% (22/122) | 1.27 | 0.000103 | 0.001886 |
GO:0043167 | ion binding | 22.13% (27/122) | 1.1 | 0.000102 | 0.00192 |
GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides | 1.64% (2/122) | 6.89 | 0.000138 | 0.002387 |
GO:0000932 | P-body | 2.46% (3/122) | 4.78 | 0.000194 | 0.003111 |
GO:1901265 | nucleoside phosphate binding | 17.21% (21/122) | 1.24 | 0.00019 | 0.003134 |
GO:0000166 | nucleotide binding | 17.21% (21/122) | 1.24 | 0.00019 | 0.003134 |
GO:0044270 | cellular nitrogen compound catabolic process | 4.1% (5/122) | 3.22 | 0.000221 | 0.00339 |
GO:0046700 | heterocycle catabolic process | 4.1% (5/122) | 3.22 | 0.000221 | 0.00339 |
GO:0043168 | anion binding | 17.21% (21/122) | 1.22 | 0.000241 | 0.003616 |
GO:1901363 | heterocyclic compound binding | 17.21% (21/122) | 1.2 | 0.000275 | 0.003937 |
GO:0035770 | ribonucleoprotein granule | 2.46% (3/122) | 4.6 | 0.000282 | 0.003957 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 2.46% (3/122) | 4.62 | 0.00027 | 0.003958 |
GO:0036094 | small molecule binding | 17.21% (21/122) | 1.19 | 0.000301 | 0.004128 |
GO:0016787 | hydrolase activity | 13.93% (17/122) | 1.35 | 0.000375 | 0.005047 |
GO:1901361 | organic cyclic compound catabolic process | 4.1% (5/122) | 3.03 | 0.00041 | 0.005397 |
GO:0032555 | purine ribonucleotide binding | 15.57% (19/122) | 1.22 | 0.000487 | 0.006298 |
GO:0032553 | ribonucleotide binding | 15.57% (19/122) | 1.21 | 0.000538 | 0.006824 |
GO:0005634 | nucleus | 10.66% (13/122) | 1.53 | 0.000614 | 0.00723 |
GO:0005737 | cytoplasm | 9.84% (12/122) | 1.61 | 0.000609 | 0.007298 |
GO:0097367 | carbohydrate derivative binding | 15.57% (19/122) | 1.2 | 0.00059 | 0.007336 |
GO:0043170 | macromolecule metabolic process | 21.31% (26/122) | 0.97 | 0.000608 | 0.007418 |
GO:0003729 | mRNA binding | 4.1% (5/122) | 2.86 | 0.000678 | 0.007835 |
GO:0140662 | ATP-dependent protein folding chaperone | 2.46% (3/122) | 4.13 | 0.000715 | 0.007851 |
GO:0003824 | catalytic activity | 30.33% (37/122) | 0.74 | 0.00071 | 0.007934 |
GO:0044281 | small molecule metabolic process | 8.2% (10/122) | 1.79 | 0.000703 | 0.007992 |
GO:0017076 | purine nucleotide binding | 15.57% (19/122) | 1.16 | 0.000774 | 0.008364 |
GO:0009057 | macromolecule catabolic process | 4.92% (6/122) | 2.44 | 0.000901 | 0.008604 |
GO:0031593 | polyubiquitin modification-dependent protein binding | 1.64% (2/122) | 5.52 | 0.000914 | 0.008606 |
GO:0030015 | CCR4-NOT core complex | 1.64% (2/122) | 5.54 | 0.000889 | 0.008617 |
GO:0043226 | organelle | 17.21% (21/122) | 1.08 | 0.000867 | 0.008661 |
GO:0000956 | nuclear-transcribed mRNA catabolic process | 2.46% (3/122) | 4.06 | 0.00082 | 0.008711 |
GO:0043933 | protein-containing complex organization | 4.92% (6/122) | 2.45 | 0.000888 | 0.008736 |
GO:0099080 | supramolecular complex | 3.28% (4/122) | 3.28 | 0.000837 | 0.008755 |
GO:0043229 | intracellular organelle | 17.21% (21/122) | 1.08 | 0.000866 | 0.008783 |
GO:0140535 | intracellular protein-containing complex | 4.92% (6/122) | 2.46 | 0.000859 | 0.008847 |
GO:0005524 | ATP binding | 12.3% (15/122) | 1.32 | 0.001024 | 0.009506 |
GO:0005525 | GTP binding | 3.28% (4/122) | 3.18 | 0.001067 | 0.009635 |
GO:0032561 | guanyl ribonucleotide binding | 3.28% (4/122) | 3.18 | 0.001067 | 0.009635 |
GO:0044183 | protein folding chaperone | 2.46% (3/122) | 3.92 | 0.001082 | 0.009639 |
GO:0046040 | IMP metabolic process | 1.64% (2/122) | 5.34 | 0.001164 | 0.010228 |
GO:0019001 | guanyl nucleotide binding | 3.28% (4/122) | 3.14 | 0.001191 | 0.010325 |
GO:0090304 | nucleic acid metabolic process | 10.66% (13/122) | 1.41 | 0.001245 | 0.010656 |
GO:0140030 | modification-dependent protein binding | 1.64% (2/122) | 5.24 | 0.00134 | 0.011322 |
GO:0018738 | S-formylglutathione hydrolase activity | 0.82% (1/122) | 9.46 | 0.00142 | 0.011848 |
GO:0006402 | mRNA catabolic process | 2.46% (3/122) | 3.75 | 0.001524 | 0.012552 |
GO:0009126 | purine nucleoside monophosphate metabolic process | 1.64% (2/122) | 5.1 | 0.001626 | 0.01261 |
GO:0009167 | purine ribonucleoside monophosphate metabolic process | 1.64% (2/122) | 5.1 | 0.001626 | 0.01261 |
GO:0009127 | purine nucleoside monophosphate biosynthetic process | 1.64% (2/122) | 5.1 | 0.001615 | 0.012826 |
GO:0009168 | purine ribonucleoside monophosphate biosynthetic process | 1.64% (2/122) | 5.1 | 0.001615 | 0.012826 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 4.1% (5/122) | 2.59 | 0.001584 | 0.012886 |
GO:0010629 | negative regulation of gene expression | 3.28% (4/122) | 3.0 | 0.0017 | 0.013023 |
GO:0022618 | protein-RNA complex assembly | 2.46% (3/122) | 3.66 | 0.001834 | 0.013889 |
GO:0005829 | cytosol | 5.74% (7/122) | 2.02 | 0.001873 | 0.01403 |
GO:0004630 | phospholipase D activity | 1.64% (2/122) | 4.98 | 0.001903 | 0.014093 |
GO:0071826 | protein-RNA complex organization | 2.46% (3/122) | 3.61 | 0.001998 | 0.014626 |
GO:0043231 | intracellular membrane-bounded organelle | 14.75% (18/122) | 1.07 | 0.002178 | 0.015774 |
GO:0006206 | pyrimidine nucleobase metabolic process | 1.64% (2/122) | 4.86 | 0.002239 | 0.016042 |
GO:0016810 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds | 2.46% (3/122) | 3.54 | 0.002301 | 0.016302 |
GO:0043227 | membrane-bounded organelle | 14.75% (18/122) | 1.06 | 0.002363 | 0.016563 |
GO:0006401 | RNA catabolic process | 2.46% (3/122) | 3.51 | 0.002457 | 0.016692 |
GO:0009161 | ribonucleoside monophosphate metabolic process | 1.64% (2/122) | 4.8 | 0.002438 | 0.016733 |
GO:0009156 | ribonucleoside monophosphate biosynthetic process | 1.64% (2/122) | 4.8 | 0.002424 | 0.016815 |
GO:1901565 | organonitrogen compound catabolic process | 4.1% (5/122) | 2.42 | 0.002636 | 0.017725 |
GO:0009123 | nucleoside monophosphate metabolic process | 1.64% (2/122) | 4.71 | 0.002757 | 0.018166 |
GO:0009124 | nucleoside monophosphate biosynthetic process | 1.64% (2/122) | 4.71 | 0.002742 | 0.018255 |
GO:0004812 | aminoacyl-tRNA ligase activity | 2.46% (3/122) | 3.43 | 0.002876 | 0.018402 |
GO:0016875 | ligase activity, forming carbon-oxygen bonds | 2.46% (3/122) | 3.43 | 0.002876 | 0.018402 |
GO:0006418 | tRNA aminoacylation for protein translation | 2.46% (3/122) | 3.43 | 0.002853 | 0.018613 |
GO:0043039 | tRNA aminoacylation | 2.46% (3/122) | 3.4 | 0.003031 | 0.019206 |
GO:0004019 | adenylosuccinate synthase activity | 0.82% (1/122) | 8.27 | 0.003243 | 0.019609 |
GO:0006167 | AMP biosynthetic process | 0.82% (1/122) | 8.27 | 0.003243 | 0.019609 |
GO:0001097 | TFIIH-class transcription factor complex binding | 0.82% (1/122) | 8.27 | 0.003243 | 0.019609 |
GO:0044208 | 'de novo' AMP biosynthetic process | 0.82% (1/122) | 8.27 | 0.003243 | 0.019609 |
GO:0043038 | amino acid activation | 2.46% (3/122) | 3.35 | 0.003318 | 0.019875 |
GO:0000212 | meiotic spindle organization | 0.82% (1/122) | 8.18 | 0.003446 | 0.020095 |
GO:0022607 | cellular component assembly | 4.1% (5/122) | 2.35 | 0.003207 | 0.020126 |
GO:0071840 | cellular component organization or biogenesis | 8.2% (10/122) | 1.47 | 0.003425 | 0.020153 |
GO:0009395 | phospholipid catabolic process | 1.64% (2/122) | 4.55 | 0.003419 | 0.020296 |
GO:0004160 | dihydroxy-acid dehydratase activity | 0.82% (1/122) | 7.94 | 0.004053 | 0.023427 |
GO:0010558 | negative regulation of macromolecule biosynthetic process | 3.28% (4/122) | 2.63 | 0.004188 | 0.023996 |
GO:0006612 | protein targeting to membrane | 1.64% (2/122) | 4.37 | 0.00434 | 0.024654 |
GO:0065003 | protein-containing complex assembly | 3.28% (4/122) | 2.6 | 0.004525 | 0.025485 |
GO:0031327 | negative regulation of cellular biosynthetic process | 3.28% (4/122) | 2.59 | 0.004628 | 0.025845 |
GO:0009112 | nucleobase metabolic process | 1.64% (2/122) | 4.31 | 0.004737 | 0.026013 |
GO:0009890 | negative regulation of biosynthetic process | 3.28% (4/122) | 2.58 | 0.004697 | 0.026013 |
GO:0005673 | transcription factor TFIIE complex | 0.82% (1/122) | 7.68 | 0.004861 | 0.026475 |
GO:0034657 | GID complex | 0.82% (1/122) | 7.62 | 0.005063 | 0.02735 |
GO:0006338 | chromatin remodeling | 2.46% (3/122) | 3.11 | 0.005314 | 0.028242 |
GO:0016043 | cellular component organization | 7.38% (9/122) | 1.48 | 0.005305 | 0.028422 |
GO:0140657 | ATP-dependent activity | 5.74% (7/122) | 1.73 | 0.005612 | 0.029587 |
GO:0016071 | mRNA metabolic process | 3.28% (4/122) | 2.51 | 0.005679 | 0.029701 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 2.46% (3/122) | 3.05 | 0.005895 | 0.03059 |
GO:0006457 | protein folding | 2.46% (3/122) | 3.05 | 0.00595 | 0.030632 |
GO:0010605 | negative regulation of macromolecule metabolic process | 3.28% (4/122) | 2.46 | 0.006357 | 0.032475 |
GO:0006325 | chromatin organization | 2.46% (3/122) | 2.98 | 0.006727 | 0.03384 |
GO:0031324 | negative regulation of cellular metabolic process | 3.28% (4/122) | 2.44 | 0.006718 | 0.034058 |
GO:0015245 | fatty acid transmembrane transporter activity | 0.82% (1/122) | 7.18 | 0.00688 | 0.034088 |
GO:0009892 | negative regulation of metabolic process | 3.28% (4/122) | 2.43 | 0.006846 | 0.034179 |
GO:0072527 | pyrimidine-containing compound metabolic process | 1.64% (2/122) | 3.97 | 0.007385 | 0.036318 |
GO:0010498 | proteasomal protein catabolic process | 2.46% (3/122) | 2.92 | 0.007646 | 0.037325 |
GO:0098727 | maintenance of cell number | 0.82% (1/122) | 6.91 | 0.00829 | 0.037678 |
GO:0010071 | root meristem specification | 0.82% (1/122) | 6.91 | 0.00829 | 0.037678 |
GO:0090421 | embryonic meristem initiation | 0.82% (1/122) | 6.91 | 0.00829 | 0.037678 |
GO:0010492 | maintenance of shoot apical meristem identity | 0.82% (1/122) | 6.91 | 0.00829 | 0.037678 |
GO:0010074 | maintenance of meristem identity | 0.82% (1/122) | 6.91 | 0.00829 | 0.037678 |
GO:0019827 | stem cell population maintenance | 0.82% (1/122) | 6.91 | 0.00829 | 0.037678 |
GO:0010078 | maintenance of root meristem identity | 0.82% (1/122) | 6.91 | 0.00829 | 0.037678 |
GO:0070150 | mitochondrial glycyl-tRNA aminoacylation | 0.82% (1/122) | 6.94 | 0.008089 | 0.038628 |
GO:0000070 | mitotic sister chromatid segregation | 0.82% (1/122) | 6.94 | 0.008089 | 0.038628 |
GO:0034660 | ncRNA metabolic process | 4.1% (5/122) | 2.03 | 0.008031 | 0.038917 |
GO:0016874 | ligase activity | 3.28% (4/122) | 2.32 | 0.008791 | 0.039682 |
GO:0006796 | phosphate-containing compound metabolic process | 9.84% (12/122) | 1.13 | 0.008862 | 0.03973 |
GO:0140096 | catalytic activity, acting on a protein | 11.48% (14/122) | 1.02 | 0.009062 | 0.040352 |
GO:0071818 | BAT3 complex | 0.82% (1/122) | 6.74 | 0.009297 | 0.040843 |
GO:0006793 | phosphorus metabolic process | 9.84% (12/122) | 1.13 | 0.009251 | 0.040915 |
GO:0090150 | establishment of protein localization to membrane | 1.64% (2/122) | 3.78 | 0.009571 | 0.041769 |
GO:0030163 | protein catabolic process | 2.46% (3/122) | 2.79 | 0.009637 | 0.041783 |
GO:0070127 | tRNA aminoacylation for mitochondrial protein translation | 0.82% (1/122) | 6.62 | 0.010101 | 0.043507 |
GO:0032559 | adenyl ribonucleotide binding | 12.3% (15/122) | 0.96 | 0.010326 | 0.043619 |
GO:0010014 | meristem initiation | 0.82% (1/122) | 6.59 | 0.010302 | 0.0438 |
GO:0140101 | catalytic activity, acting on a tRNA | 2.46% (3/122) | 2.76 | 0.010269 | 0.043944 |
GO:0071007 | U2-type catalytic step 2 spliceosome | 0.82% (1/122) | 6.54 | 0.010704 | 0.044364 |
GO:0043614 | multi-eIF complex | 0.82% (1/122) | 6.54 | 0.010704 | 0.044364 |
GO:0071540 | eukaryotic translation initiation factor 3 complex, eIF3e | 0.82% (1/122) | 6.54 | 0.010704 | 0.044364 |
GO:0003876 | AMP deaminase activity | 0.82% (1/122) | 6.38 | 0.011908 | 0.048743 |
GO:0047623 | adenosine-phosphate deaminase activity | 0.82% (1/122) | 6.38 | 0.011908 | 0.048743 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 5.74% (7/122) | 1.51 | 0.012157 | 0.048852 |
GO:0002188 | translation reinitiation | 0.82% (1/122) | 6.36 | 0.012109 | 0.048956 |
GO:0072379 | ER membrane insertion complex | 0.82% (1/122) | 6.36 | 0.012109 | 0.048956 |
GO:0071824 | protein-DNA complex organization | 2.46% (3/122) | 2.66 | 0.012362 | 0.049077 |
GO:0005851 | eukaryotic translation initiation factor 2B complex | 0.82% (1/122) | 6.34 | 0.01231 | 0.049164 |